SLABÝ, Ondřej. MicroRNAs in solid cancer: from biomarkers to therapeutic targets. In The 9th Symposium & Workshop on Molecular Pathology and Histo(cyto)chemistry; The 99th Olomouc Seminar of the Czech division of the international academy of Pathology; The 5th Olomouc days of Histology Laboratory Technicians. 2013. ISBN 978-80-7471-022-3.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MicroRNAs in solid cancer: from biomarkers to therapeutic targets
Authors SLABÝ, Ondřej (203 Czech Republic, guarantor, belonging to the institution).
Edition The 9th Symposium & Workshop on Molecular Pathology and Histo(cyto)chemistry; The 99th Olomouc Seminar of the Czech division of the international academy of Pathology; The 5th Olomouc days of Histology Laboratory Technicians, 2013.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14740/13:00065597
Organization unit Central European Institute of Technology
ISBN 978-80-7471-022-3
Keywords in English microRNAs; solid cancers; biomarkers; therapeutic targets
Changed by Changed by: Mgr. Petra Vychytilová, Ph.D., učo 211789. Changed: 27/1/2014 17:22.
Abstract
MicroRNAs (miRNAs) are small non-coding RNAs 18–25 nucleotides in length that downregulate gene expression during various crucial cell processes such as apoptosis, differentiation and development. Changes in the expression profiles of miRNAs have been observed in a variety of human solid tumors. Functional studies indicate that miRNAs act as tumor suppressors and oncogenes. These findings significantly extend concept of molecular pathogenesis of cancer and have shown great potential for miRNAs as a novel class of therapeutic targets. Several investigations have also described the ability of miRNA expression profiles to predict prognosis and response to selected treatments in cancer patients, and support diagnosis of origin among cancer of unknown primary site. MiRNAs’ occurrence has been repeatedly observed also in blood serum and plasma, and miRNAs as novel minimally invasive biomarkers have indicated reasonable sensitivity for cancer detection. This lecture covers introduction to miRNAs biology, miRNAs' involvement in the hallmarks of cancer, the knowledge regarding miRNAs' functioning in pathogenetic signaling pathways and their potential to serve as disease biomarkers and novel therapeutic targets in the colorectal cancer, renal cell carcinoma and glioblastoma in order to our recent observations.
Links
NT13514, research and development projectName: Analýza mikroRNA v glioblastomových kmenových buňkách: predikce léčebné odpovědi a identifikace nových terapeutických cílů u pacientů s glioblastomem
NT13549, research and development projectName: Vytvoření diagnostické sady cirkulujících mikroRNA pro neinvazivní časnou diagnostiku a sledování pacientů s kolorektálním karcinomem
PrintDisplayed: 10/10/2024 11:13